pyridoxamine has been researched along with Diabetes Mellitus in 9 studies
Diabetes Mellitus: A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (22.22) | 18.2507 |
| 2000's | 6 (66.67) | 29.6817 |
| 2010's | 1 (11.11) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pena-Polanco, JE | 1 |
| Fried, LF | 1 |
| Metz, TO | 1 |
| Alderson, NL | 1 |
| Chachich, ME | 1 |
| Thorpe, SR | 2 |
| Baynes, JW | 3 |
| Voziyan, PA | 1 |
| Khalifah, RG | 3 |
| Thibaudeau, C | 1 |
| Yildiz, A | 1 |
| Jacob, J | 1 |
| Serianni, AS | 1 |
| Hudson, BG | 3 |
| Jakus, V | 1 |
| Rietbrock, N | 1 |
| Ishikawa, N | 1 |
| Miyata, T | 1 |
| Kurokawa, K | 1 |
| Jain, SK | 1 |
| Booth, AA | 1 |
| Price, DL | 1 |
| Rhett, PM | 1 |
4 reviews available for pyridoxamine and Diabetes Mellitus
| Article | Year |
|---|---|
Established and Emerging Strategies in the Treatment of Chronic Kidney Disease.
Topics: Allopurinol; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Bicarbonate | 2016 |
Advanced glycation end-products and the progress of diabetic vascular complications.
Topics: Arteriosclerosis; Diabetes Complications; Diabetes Mellitus; Glycation End Products, Advanced; Glyco | 2004 |
[Carbonyl stress inhibitor towards new therapeutic interventions in diabetic nephropathy].
Topics: Amides; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihyp | 2004 |
Amadorins: novel post-Amadori inhibitors of advanced glycation reactions.
Topics: Diabetes Mellitus; Drug Design; Glycation End Products, Advanced; Guanidines; Pyridoxamine; Schiff B | 1999 |
5 other studies available for pyridoxamine and Diabetes Mellitus
| Article | Year |
|---|---|
Pyridoxamine traps intermediates in lipid peroxidation reactions in vivo: evidence on the role of lipids in chemical modification of protein and development of diabetic complications.
Topics: Animals; Arachidonic Acid; Blood Glucose; Diabetes Complications; Diabetes Mellitus; Fatty Acids, Un | 2003 |
Modification of proteins in vitro by physiological levels of glucose: pyridoxamine inhibits conversion of Amadori intermediate to advanced glycation end-products through binding of redox metal ions.
Topics: Animals; Carbon Isotopes; Diabetes Mellitus; Glucose; Glycation End Products, Advanced; Humans; Lysi | 2003 |
Can tryptophan oxidation lead to lower tryptophan level in diabetes? A commentary on "Propagation of protein glycation damage involves modification of tryptophan residues via reactive oxygen species: inhibition by pyridoxamine".
Topics: Animals; Diabetes Mellitus; Glucose; Glycation End Products, Advanced; Humans; Lipid Bilayers; Model | 2008 |
Thiamine pyrophosphate and pyridoxamine inhibit the formation of antigenic advanced glycation end-products: comparison with aminoguanidine.
Topics: Animals; Antigens; Cattle; Diabetes Complications; Diabetes Mellitus; Enzyme Inhibitors; Glycation E | 1996 |
Chelating activity of advanced glycation end-product inhibitors.
Topics: Amines; Antioxidants; Ascorbic Acid; Bromides; Chelating Agents; Copper; Diabetes Complications; Dia | 2001 |